Loading...

AURA AURA BIOSCIENCES INC Product Launches 8-K Filing

R BS

R

AURA BIOSCIENCES INC

(AURA)

2024 8-K

Aura Biosciences Update

Financial Update

Equity Offerings

Board Appointment

Financial Results

Financial Results

Clinical Trial Update

Positive Study Results

Annual Meeting and Charter ...

Investor Conferences

Financial Results Announcement

Resignation of Director

Financial Results Announcement

Investor Conferences

Underwriting Agreement

Clinical Efficacy Updates o...

Financial Results and Corpo...

Earnings Reports

Financial Results and Corpo...

Resignation of COO

Financial Results Announcement

Positive Interim Phase 2 Da...

Investor Conferences

External Links:

Aura Biosciences, Inc. announced positive Phase 2 study results for its drug bel-sar in treating early-stage choroidal melanoma, presented at a conference in Lisbon on September 12, 2024.

AI Assistant

AURA BIOSCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.